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Background. Maternal influenza vaccination protects infants against influenza virus infection. Impaired transplacental transfer 
of influenza antibodies may reduce this protection.
Methods. We conducted a cross-sectional study of influenza vaccine–naïve pregnant women recruited at delivery from Blantyre 
(urban, low malaria transmission) and Chikwawa (rural, high malaria transmission) in Southern Malawi. HIV-infected mothers 
were excluded in Chikwawa. Maternal and cord blood antibodies against circulating influenza strains A/California/7/2009, A/
Victoria/361/2011, B/Brisbane/60/2008, and B/Wisconsin/1/2010 were measured by hemagglutination inhibition (HAI). We studied 
the impact of maternal HIV infection and placental malaria on influenza antibody levels in mother–infant pairs in Blantyre and 
Chikwawa, respectively.
Results. We included 454 mother–infant pairs (Blantyre, n = 253; Chikwawa, n = 201). HIV-infected mothers and their infants 
had lower seropositivity (HAI titer ≥1:40) against influenza A(H1N1)pdm09 (mothers, 24.3 vs 45.4%; P = .02; infants, 24.3 vs 50.5%; 
P = .003) and A(H3N2) (mothers, 37.8% vs 63.9%; P = .003; infants, 43.2 vs 64.8%; P = .01), whereas placental malaria had an incon-
sistent effect on maternal and infant seropositivity. In multivariable analyses, maternal HIV infection was associated with reduced 
infant seropositivity (A(H1N1)pdm09: adjusted odds ratio [aOR], 0.34; 95% confidence interval [CI], 0.15–0.79; A(H3N2): aOR, 
0.43; 95% CI, 0.21–0.89). Transplacental transfer was not impaired by maternal HIV or placental malaria.
Conclusions. Maternal HIV infection influenced maternal antibody response to influenza A virus infection, and thereby anti-
body levels in newborns, but did not affect transplacental antibody transfer.
Keywords.  influenza; HIV; malaria; antibodies; transplacental transfer.
Pregnant women and infants under 6  months are at increased 
risk of severe influenza complications [1]. During the 2009 in-
fluenza A(H1N1) pandemic, pregnant women had higher rates 
of hospital and intensive care admissions [2, 3], as well as a 5-fold 
higher risk of death [4], compared with nongravid women. Some 
studies of pregnancy outcomes have suggested increased an risk 
of pregnancy complications attributable to maternal influenza ill-
ness; others have not [5]. The World Health Organization (WHO) 
designated pregnant women as the highest priority for influenza 
vaccination [6], though few low- and middle-income countries 
have vaccination programs targeted at pregnant women [7].
Recent randomized trials have shown that influenza vac-
cination in pregnancy not only protects the mother but also 
protects young infants against influenza and its complications 
[8, 9]. This is partly due to the reduced risk of maternal infec-
tion and transmission to the infant and partly due to active 
transplacental transfer of maternal antibodies generated from 
immunization [10]. The latter is crucial for infants <6 months, 
who have higher rates of influenza-associated hospitalization 
[11] but are ineligible to receive influenza vaccines [12].
HIV infection and malaria are prevalent in sub-Saharan 
Africa; maternal HIV infection and placental malaria have 
been associated with impaired transplacental transfer of ma-
ternal antibodies against a number of vaccine-preventable dis-
eases including tetanus, measles, and Streptococcus pneumoniae 
[13–16]. HIV-infected pregnant women are an important target 
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group for influenza vaccination, as HIV-infected adults [17] 
and pregnant women [18] have greater risk of severe influenza, 
whereas the impact of malaria co-infection is poorly studied 
[19]. Before implementing maternal influenza vaccination in 
this region, the effects of maternal HIV and placental malaria 
on maternal and newborn humoral immunity against influenza, 
as well as their potential impact on the efficacy of antenatal in-
fluenza vaccination, require evaluation. A randomized trial of 
inactivated influenza vaccine in pregnant women found lower 
seroconversion to all vaccine strains in HIV-infected mothers, 
compared with HIV-uninfected mothers, but the efficiency of 
transplacental antibody transfer was similar [20]. No studies to 
date have evaluated the effect of placental malaria on maternal–
fetal transfer of influenza antibodies.
We investigated the effect of maternal HIV infection and 
placental malaria on influenza antibody levels in unvaccinated 
pregnant women and their newborns in Malawi, a high–HIV 
and –malaria prevalence setting.
METHODS
Study Design and Setting
Between January 2013 and February 2014, we undertook a 
cross-sectional study of mother–newborn pairs at 2 sites in 
southern Malawi: (i) Queen Elizabeth Central Hospital (QECH), 
a tertiary referral government hospital in Blantyre covering an 
urban and peri-urban population of 1.3 million with a high 
HIV prevalence (17.8% among adults) [21] and low malaria 
transmission; (ii) Chikwawa District Hospital, covering a rural 
district with high year-round transmission of Plasmodium fal-
ciparum [22] and a 13.4% HIV prevalence [21]. Antiretroviral 
treatment (ART) coverage among known HIV-infected adults 
and pregnant women in Malawi was around 80% [23]. Sentinel 
severe acute respiratory illness (SARI) surveillance was under-
taken in Blantyre [24] but not in Chikwawa during the study 
period. There is no national influenza vaccination program.
Study Participants
Pregnant women aged ≥18 years presenting for delivery were en-
rolled in the labor ward at the 2 hospitals (see Supplementary Figure 1 
for eligibility criteria). Recruitment in Chikwawa was conducted 
as part of a randomized controlled trial (ISTp) that compared 
the effectiveness of scheduled intermittent screening with rapid 
diagnostic tests (RDT) and treatment with dihydroartemisinin-
pyrimethamine and intermittent preventative therapy with 
sulfadoxine-pyrimethamine to prevent malaria during pregnancy 
in HIV-negative mothers (ISRCTN Registry ISRCTN69800930) 
[25]. HIV-infected mothers were excluded from the trial.
Study Procedures
Sample Collection and Processing 
Maternal venous blood was collected within 12 hours of de-
livery. Cord blood was collected at delivery. Sera (Blantyre) and 
heparinized plasma (Chikwawa) were separated and stored at 
–80°C until analysis.
HIV status was assessed using sequential rapid tests (Alere 
Determine HIV-1/2 and Trinity Biotech Uni-Gold HIV) 
[26]. RDT for malaria (Paracheck Pf, Orchid Biomedical 
Systems, Goa, India) was performed as per the manufacturer’s 
instructions.
HAI assay was undertaken at the National Institute for 
Communicable Diseases (NICD) in Johannesburg, South 
Africa. Patient sera and plasma were treated with receptor-
destroying enzyme (Denka Seiken RDE II), then heat-
inactivated and diluted. Serial dilutions of sera and plasma 
were incubated with equal volumes of reference antigens A/
California/7/2009 (A(H1N1)pdm09), A/Victoria/361/2011 
(A(H3N2)), B/Brisbane/60/2008 (B/Victoria-lineage), and 
B/Wisconsin/1/2010 (B/Yamagata-lineage; vaccine strains 
for Southern and Northern Hemispheres during study 
period; 2012 VIDRL-WHO influenza virus typing kit: www.
influenzacentre.org) at 4 hemagglutinating units each. After 
1-hour incubation, an equal volume of 0.5% turkey red blood 
cells was added and left to settle for 45 minutes. Plates were 
visually inspected to determine HAI titers. Control reagents 
were included to monitor for nonspecific agglutination. HAI 
titer was expressed as the reciprocal of the highest serum di-
lution where heamagglutination was inhibited. HAI titers in 
sera and plasma were compared in a random subset of Blantyre 
mother–infant pairs.
After delivery, a standard questionnaire was administered to 
mothers to collect demographic data, pregnancy and childbirth 
history, and socioeconomic indicators (including maternal ed-
ucation, asset ownership, access to sanitation and water facil-
ities, and housing materials). Newborn infants were weighed 
on digital scales; infants weighing <2500 grams were classified 
as low birth weight. Due to poor recall of last menstrual period 
at the time of delivery and limited access to prenatal ultra-
sound, the gestational age of the newborn was assessed using 
the modified Ballard score [27]. Those with a gestational age 
<37 weeks were classified as preterm. A socioeconomic index, 
divided into tertiles, was generated using principal compo-
nents analysis [28].
Placental biopsies were collected and fixed in 10% neutral 
buffered formalin, then processed and embedded in paraffin 
wax. Four-micron-thin sections were stained with hematox-
ylin and eosin. The slides were read for presence of parasitized 
erythrocytes and hemozoin pigment and categorized as “active 
infection” if parasitized erythrocytes were present, “chronic 
infection” if both parasitized erythrocytes and pigmented 
macrophages were present, “past infection” if only pigment was 
present in fibrin, and “no infection” if no parasites or pigment 
was present [29]. Active and chronic infection was classified as 
“placental malaria-positive,” whereas past and no infection was 
classified as “placental malaria-negative.”
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Statistical Analysis
Analysis was stratified by site due to distinct recruitment 
periods at the 2 sites (Supplementary Figure 2), recruitment 
of HIV-infected mothers from Blantyre only, and HAI meas-
urement from different blood components (serum in Blantyre 
and plasma in Chikwawa). Thus, the impact of maternal HIV 
infection on maternal–fetal influenza antibody transfer was 
studied within Blantyre mother–infant pairs, whereas the ef-
fect of placental malaria was evaluated among Chikwawa 
mother–infant pairs.
A previous study in Malawi found a 21% and 18% reduc-
tion in placental transfer of IgG antibodies to Streptococcus 
pneumoniae by maternal HIV infection and placental malaria, 
respectively [14]. Assuming that transplacental transfer of in-
fluenza antibodies would be attenuated by a similar magnitude 
as that observed in pneumococcal antibodies, a sample size of 
225 mother–infant pairs per site would provide 80% power to 
detect a ≥20% difference in the proportion of newborns with an 
HAI titer ≥1:40 to the 4 circulating influenza strains.
Statistical analyses were performed using Stata, version 14.1 
(StataCorp LLC, College Station, TX). Baseline characteristics 
of enrolled mothers and newborns were compared using the 
X2 test for categorical data and the Wilcoxon rank-sum test for 
continuous data. Maternal and cord HAI titers against the influ-
enza A(H1N1)pdm09, A(H3N2), B/Victoria, and B/Yamagata 
viruses were logarithmically transformed to calculate geometric 
mean titers (GMTs) and 95% confidence intervals (CIs). HAI 
titers <1:10 were assigned a value of 1:5, and those with titers 
>1:1280 were assigned a titer of 1:2560. The primary end point 
was the proportion of infants with HAI titers of ≥1:40 (con-
sidered seropositive), which is associated with a ≥50% reduc-
tion in symptomatic influenza in young healthy adults [30, 31].
Logistic regression was used to estimate the association of 
maternal HIV infection and placental malaria with infant influ-
enza seropositivity, as well as the role of possible confounding 
covariates, including maternal age, parity, gestational age (<37 
or ≥37 weeks), infant birth weight (<2500 or ≥2500 grams), so-
cioeconomic status, and season of recruitment. Multivariable 
models were built using stepwise backward elimination of 
covariates with P values >.20. Significant variables were in-
cluded in the multivariable models for all 4 strains. Maternal 
HAI titers were considered to be on the causal pathway in the 
analyses of infant HAI seropositivity; hence they were excluded 
from the regression models. A 2-sided P value of <.05 was con-
sidered significant.
Linear regression models were used to investigate the impact 
of HIV and placental malaria infection on the association be-
tween log maternal and cord titers, adjusted for any identified 
risk factors for infant seropositivity. The slope of the linear re-
gression line (b1) represents the ratio between log cord and ma-
ternal HAI titers (cord-maternal ratio), providing an estimate 
of the efficiency of transplacental maternal antibody transfer.
Ethics Statement
The study was approved by the University of Malawi College 
of Medicine Research Ethics Committee, Blantyre, Malawi. 
The US Centers for Disease Control and Prevention (CDC) 
reviewed the protocol and relied on the University of Malawi 
Ethics Committee (CDC IRB#6507). Written informed consent 
was obtained from all participating women.
RESULTS
Recruitment took place between January and August 2013 in 
Chikwawa and between September 2013 and February 2014 in 
Blantyre (Supplementary Figure 2). Overall, 454 mother–new-
born pairs (Blantyre, n = 253; Chikwawa, n = 201) were included 
in the analysis (Table 1; Supplementary Figure 3). The median 
maternal age (interquartile range [IQR]) was 22 (19–28) years. 
Forty percent of women were primigravid. Thirty-seven of 253 
(14.6%) Blantyre mothers were HIV positive. Placental ma-
laria was identified in 10 of 214 (4.7%) Blantyre women and 63 
of 201 (31.3%) Chikwawa women. Only 1 enrolled mother in 
Blantyre had HIV and placental malaria co-infection. Three of 
243 (1.2%) Blantyre mothers and 38 of 200 (19.1%) Chikwawa 
mothers had a positive malaria RDT. None of the mothers had 
received influenza vaccination.
Among the newborns, 224 (49.4%) were males. The median 
gestational age of the babies (range) was 39 (30–42) weeks. 
Thirty-five of 448 (7.8%) newborns with an available Ballard 
score were preterm. Low birth weight was observed in 36 (7.9%) 
infants, of whom 17 (48.6%) were preterm.
Influenza Antibody Titers in Mothers and Infants, by Maternal HIV and 
Placental Malaria Status
The proportion of mothers and newborns with HAI titers ≥1:40 
against the circulating influenza strains and the corresponding 
GMT by maternal HIV and placental malaria status are shown 
in Supplementary Tables 1 and 2. Among Blantyre mother–in-
fant pairs, both HIV-infected mothers and their newborns had 
a lower proportion of seropositivity for influenza A(H1N1)
pdm09 and A(H3N2), compared with HIV-uninfected mother–
infant pairs (influenza A(H1N1)pdm09: mothers, 24.3% vs 
45.4%; P  =  .02; infants, 24.3% vs 50.5%; P  =  .003; influenza 
A(H3N2): mothers, 37.8% vs 63.9%; P = .003; infants, 43.2% vs 
64.8%; P = .01) (Supplementary Table 1). HIV-infected mothers 
and their infants also had significantly lower GMTs for HAI 
antibodies for both influenza A strains (GM ratio for influenza 
A(H1N1)2009, 0.59; 95% CI, 0.35–0.99; A(H3N2), 0.45, 95% 
CI, 0.29–0.71). Percent seropositivity among mother–infant 
pairs was lower for B/Victoria (8.3%–13.5%) and B/Yamagata 
(11.1%–19.9%), with no difference by HIV status.
Among Chikwawa mother–infant pairs, seropostivity to the 
4 different influenza strains varied from 66.7% to 100% among 
mothers and 66.7% to 98.6% among infants (Supplementary 
Table 2). Placental malaria was associated with lower maternal 
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seropositivity (78.7 vs 91.1%; P = .02) and GMT (121.7 vs 239.2; 
GM ratio, 0.51; 95% CI, 0.32–0.80) for influenza A(H1N1)
pdm09, but this difference was not observed in the infants. 
Placental malaria status had no impact on maternal and infant 
seropositivity for the other influenza strains, though mothers 
with placental malaria and their newborns had lower GMT 
for B/Victoria compared with those without placental malaria 
(GMT in mothers, 418.7 vs 663.9; GM ratio, 0.63; 95% CI, 0.37–
1.06; GMT in infants, 96.0 vs 150.2; GM ratio, 0.64; 95% CI, 
0.41–1.01).
In the 34 Blantyre mother–infant pairs that had HAI assay 
performed on both sera and plasma, HAI GMT from plasma 
were generally higher than the corresponding serum values 
for all 4 viruses tested, but the difference by blood compo-
nent was significant for B/Victoria (GMT, 46.6 vs 9.3; GM 
ratio, 5.01; 95% CI, 2.73–9.18) and B/Yamagata (GMT, 233.3 
vs 15.2; GM ratio, 15.36; 95% CI, 8.43–27.98) (Supplementary 
Table 3).
Factors Associated With Infant Seropositivity
Among Blantyre mother–infant pairs, maternal HIV was associ-
ated with a significantly lower proportion of infants with an HAI 
titer ≥1:40 for influenza A(H1N1)pdm09 (24.3% vs 50.5%; ad-
justed odds ratio [aOR], 0.34; 95% CI, 0.15–0.79) and A(H3N2) 
(43.2% vs 64.8%; OR, 0.43; 95% CI, 0.21–0.89) (Table 2). 
There was no association between maternal HIV and infant se-
ropositivity for the influenza B strains. Younger maternal age 
(<25 years) was associated with infant seropositivity for influ-
enza A(H1N1)pdm09 (aOR, 2.61; 95% CI, 1.54–4.45) and influ-
enza B/Yamagata (aOR, 1.83; 95% CI, 0.97–3.79). Additionally, 
January to April recruitment was associated with infant seropos-
itivity for influenza A(H1N1)pdm09 (aOR, 2.3; 95% CI, 1.34–
4.20) and influenza B/Victoria (aOR, 2.40; 95% CI, 1.13–5.10).
Placental malaria had no association with infant seroposi-
tivity for any of the influenza strains in Chikwawa (Table 3). 
Younger maternal age was associated with infant seropositivity 
against influenza A(H3N2) (71.3 vs 51.4%; aOR, 2.50; 95% CI, 
Table 1. Demographic and Clinical Characteristics of Enrolled Mothers and Infants
Characteristic
All, No. (%) Blantyre, No. (%) Chikhwawa, No. (%)
n = 454 n = 253 n = 201
Maternal
Demographics
Age, median (IQR), y 22 (19–28) 25 (19–31) 20 (17–23)
Area of residence n = 448 n = 249 n = 199
 Urban 142 (31.7) 141 (56.6) 0 (0)
 Peri-urban 67 (15.0) 67 (26.9) 0 (0)
 Rural 239 (53.3) 41 (16.5) 199 (100)
SES index score (tertiles) n = 429 n = 229 n = 200
 Low 150 (35.0) 17 (7.4) 133 (66.5)
 Medium 137 (31.9) 73 (31.9) 64 (32.0)
 High 142 (33.1) 139 (60.7) 3 (1.5)
Highest level of schooling n = 452 n = 252 n = 202
 None 33 (7.3) 6 (2.4) 27 (13.5)
 Primary 269 (59.5) 119 (47.2) 150 (75.0)
 Secondary 131 (29.0) 108 (42.9) 23 (115)
 Tertiary 19 (4.2) 19 (7.5) 0 (0)
Primigravidae 183 (40.3) 84 (33.2) 99 (49.3)
Laboratory findings    
 HIV-infected 37 (8.2) 37 (14.6)  0 (0)a 
 Placental malaria 73/415 (17.6) 10/214 (4.7) 63 (31.3)
 Positive malaria RDT 41/442 (9.3) 3/243 (1.2) 38/200 (19.1)
Newborn    
Male sex 222/440 (49.4) 123/250 (49.2) 99/200 (49.8)
Gestational ageb n = 453 n = 251 n = 197
 ≥37 wk 413 (92.2) 224 (89.2) 189 (95.9)
 <37 wk 35 (7.8) 27 (10.6) 8 (4.1)
Birth weight, median (IQR), g 3000 (2740–3200) 3000 (2800–3240) 3000 (2700–3200)
Low birth weight 36/452 (8.0) 23/257 (9.0) 13/200 (6.5)
Head circumference, mean ± SD, cm 33.3 ± 2.1 33.0 ± 2.6 33.7 ± 1.3 
Abbreviations: IQR, interquartile range; RDT, rapid diagnostic test; SES socioeconomic status.
aHIV-positive women were excluded in the Chikwawa study.
bBased on Ballard score.
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1.18–5.27). Conversely, older maternal age was associated with 
infant seropositivity for influenza B/Victoria (82.2 vs 94.7%; 
aOR, 4.29; 95% CI, 0.96–19.16). Recruitment between May and 
August was associated with increased odds of infant seroposi-
tivity for influenza B/Victoria.
Transplacental Transfer of Maternal Influenza Antibodies
Figures 1 and 2 illustrate the relationship between maternal and 
cord blood HAI titers by maternal HIV and placental malaria 
status, respectively. Among Blantyre mother–infant pairs, 
a strong positive linear relationship between maternal and 
cord HAI titers was observed for influenza A(H1N1)pdm09 
(HIV-uninfected mothers: b1 =  .825; R2 =  .695; HIV-infected 
mothers: b1 = .810; R2 = .670) and A(H3N2) (HIV-uninfected 
mothers: b1 = .841; R2 = .719; HIV-infected mothers: b1 = .834; 
R2 = .672), suggesting efficient transplacental transfer (Figure 1; 
Supplementary Table 4). In contrast, poor linear association be-
tween maternal and infant titers was observed for B/Victoria 
Table 2. Association of Maternal HIV Status and Other Factors With Infant HAI Titers ≥1:40 in Blantyre
HAI Titer ≥1:40, No. (%)
Univariablea Multivariableb
OR (95% CI) P Value aOR (95% CI) P Value
A(H1N1)pdm09      
Maternal age, y      
 18–24 71/121 (58.7) 2.57 (1.55–4.27) <.001 2.61 (1.54–4.45) <.001
 ≥25 47/132 (35.6) 1  1  
Maternal HIV status      
 Negative 109/216 (50.5) 1  1  
 Positive 9/37 (24.3) 0.32 (0.14–0.70) .005 0.34 (0.15–0.79) .01
Season of recruitment      
 Sep–Dec 70/171 (40.9) 1  1  
 Jan–Apr 48/81 (59.3) 2.10 (1.23–3.59) .007 2.38 (1.35–4.20) .003
A(H3N2)      
Maternal age, y      
 18–24 80/121 (66.1) 1.44 (0.86–2.40) .16 1.36 (0.81–2.30) .25
 ≥25 76/132 (57.6) 1  1  
Maternal HIV status      
 Negative 140/216 (64.8) 1  1  
 Positive 16/37 (43.2) 0.41 (0.20–0.84) .02 0.43 (0.21–0.89) .02
Season of recruitment      
 Sep–Dec 104/171 (60.8) 1  1  
 Jan–Apr 52/81 (64.2) 1.16 (0.67–2.00) .61 1.18 (0.67–2.06) .56
B/Victoria      
Maternal age, y      
 18–24 16/121 (13.2) 1.10 (0.53–2.32) .79 1.17 (0.55–2.50) .68
 ≥25 15/132 (12.1) 1  1  
Maternal HIV status      
 Negative 27/216 (12.5) 1  1  
 Positive 5/37 (13.5) 1.09 (0.39–3.05) .86 1.12 (0.39–3.18) .84
Season of recruitment      
 Sep–Dec 16/171 (9.4) 1  1  
 Jan–Apr 16/81 (19.8) 2.38 (1.13–5.05) .02 2.40 (1.13–5.10) .02
B/Yamagata      
Maternal age, y      
 18–24 30/121 (24.8) 1.85 (0.98–3.47)  1.84 (0.97–3.49) .06
 ≥25 20/132 (15.2) 1  1  
Maternal HIV status      
 Negative 43/216 (19.9) 1  1  
 Positive 7/37 (18.9) 0.94 (0.39–2.28) .89 1.08 (0.44–2.69) .86
Season of recruitment      
 Sep–Dec 30/171 (17.5) 1  1  
 Jan–Apr 19/81 (23.5) 1.44 (0.75–2.75) .27 1.49 (0.77–2.86) .23
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; HAI, hemagglutination inhibition.
aPotential confounders assessed: Maternal: age, socioeconomic status index, parity. Infant: sex, gestational age, birth weight. Other: season of recruitment.
bMultivariable logistic regression: Maternal age, maternal HIV status, and season of recruitment.
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and B/Yamagata. The slopes of the regression lines between 
HIV-infected and HIV-uninfected mother–infant pairs were not 
significantly different for all 4 strains, suggesting that maternal 
HIV had no impact on transplacental transfer (Supplementary 
Table 4).
Among Chikwawa mother–infant pairs, some linear associ-
ation between maternal and cord HAI titers against influenza 
A(H1N1)pdm09 was observed (placental malaria-positive 
mothers, R2  =  .456; placental malaria-negative mothers, 
R2  =  .609) and against A(H3N2) (placental malaria-positive 
mothers, R2  =  .867; placental malaria-negative mothers, 
R2  =  .691), but not for B/Victoria and B/Yamagata (Figure 
2). The slope of the regression line differed by placental ma-
laria status for influenza A(H1N1)pdm09 (placental malaria-
positive vs placental malaria-negative: b1  =  .604 vs .796; 
P = .05) and A(H3N2) (placental malaria-positive vs placental 
malaria-positive: b1  =  .970 vs .823; P  =  .06) (Supplementary 
Table 4). There was no difference in the slopes of the regres-
sion lines for B/Victoria and B/Yamagata by placental malaria 
status.
Table 3. Association of Placental Malaria and Other Factors With Infant HAI Titers ≥1:40 in Chikwawa
HAI Titer ≥1:40, No. (%)
Univariablea Multivariableb
OR (95% CI) P Value aOR (95% CI) P Value
A(H1N1)pdm09      
Maternal age, y      
 18–24 135/158 (85.4) 0.50 (0.14–1.77) .29 0.53 (0.15–1.92) .34
 ≥25 35/38 (92.1) 1  1  
Placental malaria      
 Negative 119/135 (88.2) 1  1  
 Positive 51/61 (83.6) 0.69 (0.29–1.61) .39 0.73 (0.31–1.75) .48
Season of recruitment      
 Jan–Apr 126/145 (86.9) 1.05 (0.42–2.68) .91 1.06 (0.41–2.72) .90
 May–Aug 44 (86.3) 1  1  
A(H3N2)      
Maternal age, y      
 18–24 114/160 (71.3) 2.35 (1.13–4.87) .02 2.50 (1.18–5.27) .02
 ≥25 19/37 (51.4) 1  1  
Placental malaria      
 Negative 91/134 (67.9) 1  1  
 Positive 42/63 (66.7) 0.95 (0.50–1.78) .86 0.80 (0.41–1.55) .51
Season of recruitment      
 Jan–Apr 101/147 (68.7) 1.24 (0.63–2.42) .61 1.32 (0.66–2.64) .43
 May–Aug 32/50 (64.0) 1  1  
B/Victoria      
Maternal age, y      
 18–24 134/163 (82.2) 1  1  
 ≥25 36/38 (94.7) 3.90 (0.89–17.10) .07 4.29 (0.96–19.16) .06
Placental malaria      
 Negative 118/138 (85.5) 1  1  
 Positive 52/63 (82.5) 0.80 (0.36–1.79) .59 1.01 (0.44–2.33) .98
Season of recruitment      
 Jan–Apr 121/150 (80.7) 1  1  
 May–Aug 49/51 (96.1) 5.87 (1.35–25.56) .02 6.27 (1.43–27.48) .02
B/Yamagata      
Maternal age, y      
 18–24 161/163 (98.8) 2.18 (0.19–24.6) .53 2.39 (0.19–29.40) .50
 ≥25 37/38 (97.4) 1  1  
Placental malaria      
 Negative 136/138 (98.6) 1  1  
 Positive 62/63 (98.4) 0.93 (0.08–10.40) .95 0.74 (0.06–9.16) .81
Season of recruitment      
 Jan–Apr 148/150 (98.7) 1.38 (0.13–16.67) .75 1.61 (0.14–18.89) .70
 May–Aug 50/51 (98.0) 1    
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; HAI, hemagglutination inhibition.
aPotential confounders assessed: Maternal: age, socioeconomic status index, parity. Infant: sex, gestational age, birth weight. Other: season of recruitment.
bMultivariable logistic regression. Maternal age, placental malaria, and season of recruitment were included in all multivariable models.
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DISCUSSION
HIV-infected mothers and their newborns had lower percent 
seropositivity and HAI titers to influenza A, but not B viruses, 
compared with HIV-negative mother–infant pairs. Maternal 
HIV infection did not affect transplacental antibody transfer. 
In contrast, placental malaria had no consistent impact on ma-
ternal and newborn influenza antibody levels or transplacental 
transfer. Season of recruitment and young maternal age were 
also independently associated with infant seropositivity.
There are 2 possible explanations for the lower antibody re-
sponses observed in HIV-infected mothers: (i) HIV-infected 
mothers generate weaker humoral responses to influenza virus 
infection than mothers without HIV, and (ii) HIV-infected preg-
nant women avoid crowded areas to mitigate infection exposure 
and therefore have a lower probability of influenza infection. 
Existing evidence supports the former; an influenza vaccine 
trial in pregnant women found lower antibody responses to all 
3 vaccine strains in HIV-infected mothers, compared with HIV-
uninfected women [20]. Interestingly, lower HAI titers did not 
translate to poorer clinical efficacy [9]. Infants of HIV-infected 
mothers also had lower titers, but insufficient power pre-
cluded evaluation of vaccine efficacy [20]. Second, studies have 
reported a greater burden of symptomatic influenza in adults 
[17] and pregnant women [18] with HIV infection than those 
without HIV. Therefore, it seems unlikely that HIV-infected 
mothers in our study would have experienced fewer influenza 
infections than HIV-uninfected women. Furthermore, a study 
exploring the community perceptions of influenza in Malawi 
did not identify avoidance of crowded places as a known 
strategy to prevent the spread of influenza [32]. We found no 
difference in influenza B/Victoria and B/Yamagata seroposi-
tivity by maternal HIV status, which we speculate may be due to 
the comparatively low prevalence of influenza B seropositivity 
among Blantyre mother–infant pairs.
Malaria infection during pregnancy can affect antibody re-
ceptors on the placental surface [33]. Several studies have re-
ported reduced transfer of antibodies against measles [14, 
33] and tetanus [13, 16] in the presence of placental malaria, 
whereas others have not [15]. To our knowledge, the effect of 
placental malaria on the transplacental transfer of influenza 
antibodies has not been evaluated. We found no association 
between placental malaria and infant influenza seropositivity. 
Additionally, placental malaria had no consistent impact on 
transplacental transfer of influenza antibodies; it was associated 
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Figure 1. Relationship between maternal and newborn HAI titers among Blantyre mother–infant pairs by maternal HIV status. Abbreviations: Ab, antibody; HAI, hemag-
glutination inhibition.
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with less efficient transfer of influenza A(H1N1)pdm09 anti-
bodies, but more efficient antibody transfer to A(H3N2). Scott 
et  al. found reduced transplacental transfer of measles anti-
bodies only in mothers with active chronic placental malaria 
infection [15]. We classified acute and chronic placental malaria 
as “positive” and those with past placental malaria infection as 
“negative.” A  sensitivity analysis demonstrated no difference 
in transplacental transfer when placental malaria status was 
stratified as acute, chronic, past, or no infection, except for 
those with acute infection for influenza A/California/7/2009 
(Supplementary Figure 4). The observed difference in the slope 
of the regression line is not significant as there was no linear 
relationship between log maternal and infant titer (R2 = .033).
Infants with mothers aged <25  years had an approxi-
mately 2-fold increased odds of seropositivity against influ-
enza A(H1N1)pdm09 and B/Yamagata in Blantyre, as well 
as A(H3N2) in Chikwawa, compared with infants of older 
mothers. Young age was also a predictor of antibody response 
in several influenza vaccine studies in HIV-infected and 
HIV-uninfected adults [20, 34]. In HIV-uninfected young in-
dividuals, this may be due to better thymic function [20]. In 
HIV-infected adults, poorer antibody response with increasing 
age may be associated with longer duration of HIV infection or, 
with the former national HIV treatment guidelines that recom-
mended commencement of ART at a lower CD4+ threshold, a 
longer duration of HIV-mediated immune dysregulation before 
ART initiation.
Influenza seropositivity was high among mothers and their 
newborns to the influenza A  viruses in Blantyre and to all 4 
circulating influenza viruses in Chikwawa. In the context of no 
influenza vaccination coupled with evidence of influenza virus 
circulation, it is reasonable to assume that detected antibodies 
reflect exposure to natural influenza infection. Seropositivity 
and GMTs varied substantially between Blantyre and Chikwawa 
mother–infant pairs, particularly for influenza B viruses. 
Although information on circulating influenza strains was only 
available in Blantyre, we postulate that this variability is partly 
due to exposure to different circulating strains from distinct re-
cruitment periods. Moreover, the different blood components 
on which HAI assays were performed is likely a contributory 
factor. Analysis of paired plasma and sera in our subset of 
Blantyre samples demonstrated significantly higher HAI titers 
from plasma compared with sera for the influenza B viruses, 
which has been previously reported [35].
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Figure 2. Relationship between maternal and newborn HAI titers among Chikwawa mother–infant pairs by placental malaria status. Abbreviations: Ab, antibody; HAI, 
hemagglutination inhibition; PM, placental malaria.
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Our study had several limitations. First, because pregnant 
women were recruited at the time of delivery, we were unable 
to determine the maternal history of influenza infection and 
could not definitively conclude whether low maternal antibody 
levels were due to poor response to natural infection or ab-
sence of exposure. Second, CD4+ cell count and ART status of 
HIV-infected mothers were not captured. Thus we were unable 
to assess the effect of varying degrees of immunosuppression 
on antibody responses in HIV-infected mothers and infants. 
Third, analysis was stratified by site as a result of the differences 
in recruitment time periods, blood components used for HAI 
titer, and eligibility criteria (HIV-infected women excluded in 
Chikwawa), thus precluding evaluation of the effect of maternal 
HIV and placental malaria co-infection and their potential in-
teraction on transplacental influenza antibody transfer, as only 
1 mother from Blantyre had dual infection. Misclassification of 
prematurity is possible, as the modified Ballard score is prone to 
inter-rater variability [36] and tends to overestimate gestational 
age [37]. Lastly, we chose a cord HAI titer of ≥1:40 as a correlate 
for protection [30, 31]. Some have argued that higher HAI titers 
(eg, 1:110) may be required to provide protection against influ-
enza in children due to an immature cellular immune system 
and a lack of immunological memory [38]. Furthermore, a re-
cent study suggested that microneutralization (MN) titers may 
be better predictors of protection compared with HAI [39].
In summary, infants of HIV-infected mothers were more 
likely to be seronegative and have lower antibody titers to influ-
enza A viruses, which we postulate is due to an attenuated ma-
ternal antibody response to natural influenza infection rather 
than reduced efficiency of placental transfer. In contrast, pla-
cental malaria had no consistent impact with infant influenza 
seropositivity or transplacental transfer. These findings suggest 
that influenza vaccines targeting pregnant women may have var-
iable efficacy in sub-Saharan Africa, where up to 35% of women 
of childbearing age may be HIV infected [40]. Adjuvanted pre-
parations or higher doses to boost maternal antibodies may 
be required to optimize protection for HIV-infected pregnant 
women and their infants, which will impact the cost-effective-
ness of maternal influenza immunization interventions. Further 
studies are needed to define the best correlate of protection 
against influenza disease in HIV-infected persons and clarify 
whether the attenuated antibody response observed in infants 
of HIV-infected women results in reduced clinical protection, 
if it is compounded by dual maternal HIV and placental ma-
laria infection, and whether ART improves influenza antibody 
responses in HIV-infected mothers and infants.
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